Bioquímica y Biología Molecular
Department
RAKEL
LOPEZ DE MATURANA GARMENDIA
Researcher in the period 2005-2014
Publications by the researcher in collaboration with RAKEL LOPEZ DE MATURANA GARMENDIA (19)
2018
-
LRRK2 expression is deregulated in fibroblasts and neurons from parkinson patients with mutations in PINK1
Molecular Neurobiology, Vol. 55, Núm. 1, pp. 506-516
-
iPS Cell Cultures from a Gerstmann-Sträussler-Scheinker Patient with the Y218N PRNP Mutation Recapitulate tau Pathology
Molecular Neurobiology, Vol. 55, Núm. 4, pp. 3033-3048
2016
-
Mutations in LRRK2 impair NF-ΚB pathway in iPSC-derived neurons
Journal of Neuroinflammation, Vol. 13, Núm. 1
2014
-
Leucine-rich repeat kinase 2 modulates cyclooxygenase 2 and the inflammatory response in idiopathic and genetic Parkinson's disease
Neurobiology of Aging, Vol. 35, Núm. 5, pp. 1116-1124
-
Selection based on FOXA2 expression is not sufficient to enrich for dopamine neurons from human pluripotent stem cells
Stem Cells Translational Medicine, Vol. 3, Núm. 9, pp. 1032-1042
-
Sustained Increase of PKA Activity in the Postcommissural Putamen of Dyskinetic Monkeys
Molecular Neurobiology, Vol. 50, Núm. 3, pp. 1131-1141
2013
-
The LRRK2 G2019S mutant exacerbates basal autophagy through activation of the MEK/ERK pathway
Cellular and Molecular Life Sciences, Vol. 70, Núm. 1, pp. 121-136
2012
-
The MAPK1/3 pathway is essential for the deregulation of autophagy observed in G2019S LRRK2 mutant fibroblasts
Autophagy, Vol. 8, Núm. 10, pp. 1537-1539
2010
-
Functional coupling of Cys-226 and Cys-296 in the glucagon-like peptide-1 (GLP-1) receptor indicates a disulfide bond that is close to the activation pocket
Peptides, Vol. 31, Núm. 12, pp. 2289-2293
-
Mecanismos implicados en la mejora cognitiva inducida por Rosiglitazona en un modelo animal de enfermedad de Alzheimer: XXXI Congreso Nacional de la SEF: póster premiado
Actualidad en farmacología y terapéutica, Vol. 8, Núm. 1, pp. 71-74
-
Regulation of corticostriatal synaptic plasticity by G protein-coupled receptors
CNS and Neurological Disorders - Drug Targets, Vol. 9, Núm. 5, pp. 601-615
-
Rosiglitazone rescues memory impairment in Alzheimer's transgenic mice: Mechanisms involving a reduced amyloid and tau pathology
Neuropsychopharmacology, Vol. 35, Núm. 7, pp. 1593-1604
2009
-
Early changes in hippocampal eph receptors precede the onset of memory decline in mouse models of alzheimer's disease
Journal of Alzheimer's Disease, Vol. 17, Núm. 4, pp. 773-786
-
Overexpression of wild-type human APP in mice causes cognitive deficits and pathological features unrelated to Aβ levels
Neurobiology of Disease, Vol. 33, Núm. 3, pp. 369-378
2008
-
Gonadotropin-releasing hormone analog structural determinants of selectivity for inhibition of cell growth: Support for the concept of ligand-induced selective signaling
Molecular Endocrinology, Vol. 22, Núm. 7, pp. 1711-1722
2007
-
GnRH-mediated DAN production regulates the transcription of the GnRH receptor in gonadotrope cells
NeuroMolecular Medicine, Vol. 9, Núm. 3, pp. 230-248
-
Peptide binding at the GLP-1 receptor
Biochemical Society Transactions
2006
-
Gonadotropin-releasing hormone functionally antagonizes testosterone activation of the human androgen receptor in prostate cells through focal adhesion complexes involving Hic-5
Neuroendocrinology, Vol. 84, Núm. 5, pp. 285-300
2005
-
Class II G protein-coupled receptors and their ligands in neuronal function and protection
NeuroMolecular Medicine, Vol. 7, Núm. 1-2, pp. 3-36